Profile data is unavailable for this security.
About the company
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
- Revenue in USD (TTM)465.31m
- Net income in USD-44.70m
- Incorporated2000
- Employees1.20k
- LocationAtriCure Inc7555 Innovation WayMASON 45040United StatesUSA
- Phone+1 (513) 755-4100
- Fax+1 (513) 755-4567
- Websitehttps://www.atricure.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Myriad Genetics Inc | 823.60m | -116.00m | 1.33bn | 2.70k | -- | 1.81 | -- | 1.61 | -1.30 | -1.30 | 9.21 | 8.04 | 0.7385 | 9.91 | 6.84 | 305,037.00 | -10.40 | -- | -12.43 | -- | 69.15 | -- | -14.08 | -- | 1.73 | -105.00 | 0.0506 | -- | 11.03 | -- | -135.09 | -- | -- | -- |
| 10X Genomics Inc | 610.79m | -182.63m | 1.51bn | 1.31k | -- | 2.12 | -- | 2.47 | -1.52 | -1.52 | 5.07 | 5.81 | 0.6485 | 2.50 | 6.03 | 467,676.10 | -19.39 | -25.61 | -22.29 | -29.19 | 67.91 | 74.03 | -29.90 | -47.52 | 4.26 | -- | 0.00 | -- | -1.28 | 19.96 | 28.41 | -- | -20.72 | -- |
| Alphatec Holdings Inc | 572.74m | -177.87m | 1.52bn | 839.00 | -- | -- | -- | 2.66 | -1.27 | -1.27 | 4.08 | 0.1546 | 0.8089 | 1.11 | 7.73 | 682,644.80 | -25.12 | -30.97 | -32.00 | -39.47 | 69.47 | 66.02 | -31.06 | -46.22 | 1.15 | -3.66 | 0.9596 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Premier Inc | 1.18bn | 36.24m | 1.62bn | 2.90k | 53.55 | 0.9483 | 10.10 | 1.37 | 0.3318 | -0.0997 | 11.45 | 18.74 | 0.3387 | -- | 2.62 | 407,335.20 | 1.11 | 7.08 | 1.39 | 8.95 | 68.38 | 61.29 | 3.26 | 16.05 | -- | -- | 0.3218 | 27.32 | 0.7684 | 2.03 | -31.70 | -11.93 | -2.76 | -- |
| Omnicell Inc | 1.11bn | 12.53m | 1.83bn | 3.66k | 150.99 | 1.48 | 18.90 | 1.65 | 0.2623 | 0.2623 | 24.04 | 26.84 | 0.5116 | 6.42 | 4.38 | -- | 0.5764 | 1.07 | 0.7405 | 1.40 | 42.65 | 45.50 | 1.13 | 1.93 | 1.22 | -- | 0.2151 | -- | -3.04 | 4.39 | 161.51 | -27.21 | -3.06 | -- |
| Integra Lifesciences Holdings Corp | 1.56bn | -6.54m | 1.87bn | 3.95k | -- | 1.23 | 14.61 | 1.19 | -0.0881 | -0.0881 | 20.22 | 19.73 | 0.401 | 1.59 | 5.99 | 396,583.90 | -0.1677 | 3.33 | -0.2002 | 3.68 | 59.29 | 63.67 | -0.4182 | 7.99 | 0.7261 | 4.05 | 0.5428 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
| Conmed Corp | 1.31bn | 132.42m | 1.95bn | 4.00k | 14.82 | -- | 9.55 | 1.49 | 4.26 | 4.26 | 42.11 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 56.16 | 55.20 | 10.13 | 3.44 | -- | 5.43 | -- | -- | 5.00 | 6.47 | 105.44 | 35.85 | -- | 0.00 |
| UFP Technologies Inc | 461.85m | 54.21m | 1.98bn | 3.09k | 36.80 | 6.00 | 29.39 | 4.28 | 7.00 | 7.00 | 59.64 | 42.89 | 0.8896 | 4.18 | 6.15 | 149,320.40 | 10.44 | 9.69 | 12.00 | 10.95 | 28.31 | 26.33 | 11.74 | 10.14 | 1.43 | 13.44 | 0.3919 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
| AtriCure Inc | 465.31m | -44.70m | 2.00bn | 1.20k | -- | 4.33 | -- | 4.29 | -0.9518 | -0.9518 | 9.91 | 9.46 | 0.7608 | 1.64 | 8.25 | -- | -7.31 | -3.84 | -8.31 | -4.25 | 74.69 | 74.53 | -9.61 | -7.13 | 2.62 | -23.18 | 0.1183 | -- | 16.55 | 15.05 | -46.85 | -- | -- | -- |
| Neogen Corp | 913.83m | -476.33m | 2.13bn | 2.92k | -- | 0.799 | -- | 2.33 | -2.20 | -2.20 | 4.22 | 12.30 | 0.2111 | 2.59 | 5.81 | 313,276.70 | -11.01 | 1.38 | -11.44 | 1.44 | 49.09 | 48.23 | -52.12 | 4.31 | 2.46 | 0.9683 | 0.2506 | 0.00 | 12.37 | 17.41 | 58.81 | -- | 50.02 | -- |
| Tandem Diabetes Care Inc | 854.35m | -126.78m | 2.20bn | 2.40k | -- | 9.24 | -- | 2.57 | -1.94 | -1.94 | 13.08 | 3.62 | 0.9004 | 2.90 | 8.23 | 355,979.60 | -13.36 | -10.08 | -17.47 | -12.23 | 49.79 | 51.77 | -14.84 | -11.59 | 2.32 | -- | 0.5945 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
| LeMaitre Vascular Inc | 213.03m | 41.32m | 2.22bn | 614.00 | 54.11 | 6.70 | 43.53 | 10.41 | 1.82 | 1.82 | 9.41 | 14.73 | 0.5992 | 1.11 | 7.59 | 346,952.80 | 11.62 | 9.02 | 12.66 | 9.93 | 68.34 | 65.83 | 19.40 | 15.45 | 5.52 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
| TransMedics Group Inc | 401.09m | 32.64m | 2.42bn | 584.00 | 76.88 | 11.54 | 48.02 | 6.04 | 0.9389 | 0.9389 | 11.60 | 6.25 | 0.5439 | 3.56 | 5.32 | 686,797.90 | 4.43 | -16.08 | 4.78 | -17.95 | 59.34 | 65.37 | 8.14 | -40.47 | 7.33 | -- | 0.7078 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
| Novocure Ltd | 577.74m | -149.78m | 2.43bn | 1.45k | -- | 6.74 | -- | 4.21 | -1.39 | -1.39 | 5.37 | 3.34 | 0.4879 | 3.59 | 8.74 | 397,617.30 | -12.65 | -7.74 | -20.29 | -8.95 | 76.42 | 77.22 | -25.93 | -14.69 | 1.44 | -- | 0.6446 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
| Enovis Corp | 2.00bn | -121.38m | 2.50bn | 6.55k | -- | 0.7362 | 17.06 | 1.25 | -2.21 | -2.17 | 36.43 | 59.61 | 0.4023 | 1.59 | 5.91 | 305,598.20 | -2.43 | -0.3569 | -2.66 | -0.41 | 56.96 | 48.19 | -6.03 | -1.06 | 1.12 | 0.9889 | 0.2876 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
| LivaNova PLC | 1.24bn | 23.68m | 2.59bn | 2.90k | 111.94 | 1.98 | 38.15 | 2.09 | 0.4259 | 0.4259 | 22.81 | 24.13 | 0.5119 | 2.47 | 6.42 | 428,185.90 | 0.9777 | -6.01 | 1.12 | -7.42 | 67.78 | 66.99 | 1.91 | -13.56 | 2.87 | 2.46 | 0.3234 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
Data as of Feb 14 2025. Currency figures normalised to AtriCure Inc's reporting currency: US Dollar USD
51.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2024 | 4.53m | 9.29% |
| AllianceBernstein LPas of 31 Dec 2024 | 3.84m | 7.87% |
| BlackRock Fund Advisorsas of 31 Dec 2024 | 3.66m | 7.52% |
| Hood River Capital Management LLCas of 31 Dec 2024 | 2.92m | 6.00% |
| Champlain Investment Partners LLCas of 31 Dec 2024 | 2.53m | 5.19% |
| Macquarie Investment Management Business Trustas of 31 Dec 2024 | 2.38m | 4.87% |
| First Light Asset Management LLCas of 31 Dec 2024 | 1.97m | 4.04% |
| SSgA Funds Management, Inc.as of 31 Dec 2024 | 1.35m | 2.76% |
| Geode Capital Management LLCas of 31 Dec 2024 | 1.15m | 2.36% |
| GW&K Investment Management LLCas of 31 Dec 2024 | 1.00m | 2.05% |
More ▼
Data from 31 Dec 2024 - 31 Dec 2024Source: FactSet Research Systems Inc.
